Bausch + Lomb and Modulight Announce FDA Approval of Photodynamic Laser for Use with VISUDYNE®

Bausch + Lomb and Modulight Corporation, a biomedical laser company, today announced that the FDA has approved the ML6710i photodynamic laser for equivalent use with Bausch + Lomb’s VISUDYNE® (verteporfin for injection) photodynamic therapy (PDT).

Bausch + Lomb and Modulight Announce FDA Approval of Photodynamic Laser for Use with VISUDYNE®
February 01, 2023
Eyenuk Secures First MDR Certification for EyeArt® AI Screening System in the EU

Eyenuk has received approval to market its EyeArt® AI eye screening system in the European Union for the new uses of detecting age-related macular degeneration (AMD) and glaucomatous optic nerve damage.

Eyenuk Secures First MDR Certification for EyeArt® AI Screening System in the EU
February 01, 2023
Researchers Develop Contact Lens to Prevent Dry Eye Disease

A collaborative team from the Terasaki Institute for Biomedical Innovation (TIBI) has developed a contact lens prototype that is specifically designed to prevent contact lens-induced dry eye (CLIDE).

Researchers Develop Contact Lens to Prevent Dry Eye Disease
January 31, 2023
HuidaGene Receives FDA Clearance for Inherited Blindness Trial

HuidaGene Therapeutics has received clearance from the FDA for its investigational new drug (IND) application submitted for a planned multi-national clinical trial of HG004 to treat patients with inherited retinal dystrophies linked to RPE65 mutations.

HuidaGene Receives FDA Clearance for Inherited Blindness Trial
January 31, 2023
New Study Reveals Negative Effect of Atropine Drops After Glaucoma Surgery

According to a report by an international team of researchers, atropine instillation after trabeculectomy should be discouraged since it causes greater and longer lasting reduction in visual quality.

New Study Reveals Negative Effect of Atropine Drops After Glaucoma Surgery
January 30, 2023
Researchers Explore Why Episodes of Low Blood Sugar Worsen Eye Disease in People with Diabetes

Researchers at Johns Hopkins Medicine say they have linked low blood sugar levels in people with diabetes with a molecular pathway that is turned on in oxygen-starved cells in the eye.

Researchers Explore Why Episodes of Low Blood Sugar Worsen Eye Disease in People with Diabetes
January 30, 2023
Regeneron Wins Patent Case Against Novartis for Its Eye Drug Eylea

Regeneron Pharmaceuticals Inc. has won a patent case against Novartis AG in a U.S. court, protecting the company's drug delivery system for its eye drug Eylea.

Regeneron Wins Patent Case Against Novartis for Its Eye Drug Eylea
January 27, 2023
FDA Accepts Oxular’s IND Application for the Treatment of Diabetic Macular Edema

The U.S. Food and Drug Administration has approved Oxular Limited's investigational new drug application (IND) for suprachoroidal OXU-001 for the treatment of diabetic macular edema (DME).

FDA Accepts Oxular’s IND Application for the Treatment of Diabetic Macular Edema
January 26, 2023
Ophthalmologists Report a Fungal Endophthalmitis Outbreak After Cataract Surgery in S. Korea

Researchers in Seoul, Korea, under the direction of Seong Woo Kim, MD, PhD, found that early treatment may improve the prognosis of fungal endophthalmitis caused by contaminated medical supplies.

Ophthalmologists Report a Fungal Endophthalmitis Outbreak After Cataract Surgery in S. Korea
January 25, 2023
Loophole Enables FDA 510 (k) Approval of Unsafe Medical Devices, Yale Study Finds

Manufacturers, through a loophole in federal law, can use an unsafe medical device as a basis for authorization by the U.S. Food and Drug Administration (FDA) to bring new, related products to market, a Yale-led study finds.

Loophole Enables FDA 510 (k) Approval of Unsafe Medical Devices, Yale Study Finds
January 24, 2023
More